• Dosage of Afrin Menthol Saline in details
• Afrin Menthol Saline interactions
• Afrin Menthol Saline reviews

Dosage of Afrin Menthol Saline in details

Afrin Menthol Saline Dosage

Applies to the following strengths: 0.65%; buffered 0.9%; 0.4%; 3%; 0.2%; 0.9%; 2.1%; 0.5%

Usual Adult Dose for:

• Nasal Congestion

Usual Pediatric Dose for:

• Nasal Congestion

Additional dosage information:

• Renal Dose Adjustments
• Liver Dose Adjustments
• Dialysis

Usual Adult Dose for Nasal Congestion

Afrin Menthol Saline buffered 0.9% powder for reconstitution:

Nasally once or twice daily.

Afrin Menthol Saline 0.2% spray:

1 or 2 sprays in each nostril every 4 hours as needed.

Usual Pediatric Dose for Nasal Congestion

Afrin Menthol Saline buffered 0.9% powder for reconstitution:

5 years or older: Nasally once or twice daily.

Afrin Menthol Saline 0.2% spray:

2 years or older: 1 spray in each nostril every 4 hours as needed.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

More about Afrin Menthol Saline

• Afrin Menthol Saline Side Effects
• 19 Reviews
• Drug class: nasal lubricants and irrigations

Consumer resources

• Afrin Menthol Saline

Other brands: Saline Nasal Mist, Ocean, Ayr Saline Nasal, Deep Sea Nasal Spray,... +14 more

Related treatment guides

• Nasal Congestion

What other drugs will affect Afrin Menthol Saline?

Since Afrin Menthol Saline does not contain an active medicine, it is not likely to be affected by other drugs you use. But many drugs can interact with each other. Tell each of your healthcare providers about all medicines you use, including prescription and over-the-counter medicines, vitamins, and herbal products.

Afrin Menthol Saline interactions

Afrin Menthol Saline may increase the ototoxic potential of aminoglycoside antibiotics, especially in the presence of impaired renal function. Except in life-threatening situations, avoid this combination.

Afrin Menthol Saline should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity. Patients receiving high doses of salicylates concomitantly with furosemide, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.

Afrin Menthol Saline has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine.

Lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity.

Afrin Menthol Saline may add to or potentiate the therapeutic effect of other antihypertensive drugs. Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.

Afrin Menthol Saline may decrease arterial responsiveness to norepinephrine. However, norepinephrine may still be used effectively.

Tablets

Simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide. Patients receiving both drugs should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved. The intake of furosemide and sucralfate should be separated by at least two hours.

Tablets, Injection, and

Oral Solution

One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency. There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when furosemide was used in conjunction with NSAIDs.

Literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis. Indomethacin may also affect plasma renin levels, aldosterone excretion, and renin profile evaluation. Patients receiving both indomethacin and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved.

References

1. DailyMed. "AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. FDA/SPL Indexing Data. "451W47IQ8X: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. MeSH. "MeSH Tree: MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.". http://www.nlm.nih.gov/mesh/meshhome... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Afrin Menthol Saline are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Afrin Menthol Saline. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 18 here

Information checked by Dr. Sachin Kumar, MD Pharmacology